Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 63, Issue 8, 2011, Pages 2504-2515

  Cosmi, Lorenzo ^a   Cimaz, Rolando ^b   Maggi, Laura ^a   Santarlasci, Veronica ^a   Capone, Manuela ^a   Borriello, Francesco ^c   Frosali, Francesca ^a   Querci, Valentina ^a   Simonini, Gabriele ^b   Barra, Giusi ^c   Piccinni, Marie Pierre ^a   Liotta, Francesco ^a   De Palma, Raffaele ^c   Maggi, Enrico ^a   Romagnani, Sergio ^a   Annunziato, Francesco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD161 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; FLURBIPROFEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; NAPROXEN;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; JUVENILE RHEUMATOID ARTHRITIS; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SYNOVIAL FLUID; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERLEUKIN-17; MALE; SYNOVIAL FLUID; TH1 CELLS; TH17 CELLS;

EID: 79961117793     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30332     Document Type: Article

References (44)

1. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-8. (Pubitemid 36227625)
2. Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198: 1951-8.
3. Iwakura Y, Ishigame H,. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006; 116: 1218-22.
4. Dubin PJ, Kolls JK,. Th17 cytokines and mucosal immunity. Immunol Rev 2008; 226: 160-71.
5. Ouyang W, Koli JK, Zheng Y,. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-67. (Pubitemid 351471762)
6. + T helper cells. Cell 2006; 26: 1121-31.
7. H17 lineage. Nature 2006; 441: 231-4.
8. Huber M, Brustle A, Reinhard K, Guralnik A, Walter G, Mahiny A, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A 2008; 105: 20846-51.
9. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-46. (Pubitemid 46785128)
10. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-61. (Pubitemid 47240944)
11. Santarlasci V, Maggi L, Capone M, Frosali F, Querci V, De Palma R, et al. TGF-β indirectly favours the development of human Th17 cells by inhibiting Th1 cells. Eur J Immunol 2009; 39: 207-15.
12. + T-cell precursor. J Exp Med 2008; 205: 1903-16.
13. Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 2009; 206: 525-34.
14. Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 2010; 40: 2174-81.
15. Ravelli A, Martini A,. Juvenile idiopathic arthritis. Lancet 2007; 369: 767-78.
16. Imboden JB,. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 2009; 4: 417-34.
17. Prakken BJ, Albani S,. Using biology of disease to understand and guide therapy of JIA. Best Pract Res Clin Rheumatol 2009; 23: 599-608.
18. Macaubas C, Nguyen K, Milojevic D, Park JL, Mellins ED,. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol 2009; 5: 616-26.
19. Murray KJ, Luyrink L, Grom AA, Passo MH, Emery H, Witte D, et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol 1996; 23: 2116-24. (Pubitemid 27006760)
20. Gregorio A, Gambini C, Gerloni V, Parafioriti A, Sormani MP, Gregorio S, et al. Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) 2007; 46: 308-13. (Pubitemid 46189794)
21. De Jager W, Hoppenreijs EP, Wulffraat NM,. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007; 66: 589-98. (Pubitemid 46707126)
22. Nistala K, Moncrieffe H, Newton KR, Varsani H, Hunter P, Wedderburn LR,. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum 2008; 58: 875-87. (Pubitemid 351364887)
23. Agarwal S, Misra R, Aggarwal A,. Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 2008; 35: 515-9. (Pubitemid 351374430)
24. Olivito B, Simonini G, Ciullini S, Moriondo M, Betti L, Gambineri E, et al. Th17 transcription factor RORC2 is inversely correlated with FOXP3 expression in the joints of children with juvenile idiopathic arthritis. J Rheumatol 2009; 36: 2017-24.
25. Nistala K, Wedderburn LR,. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford) 2009; 48: 602-6.
26. Wehrens EJ, van Wijk F, Roord ST, Albani S, Prakken BJ,. Treating arthritis by immunomodulation: is there a role for regulatory T cells? Rheumatology (Oxford) 2010; 49: 1632-44.
27. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-4. (Pubitemid 28459316)
28. De Palma R, Gorski J,. Restricted and conserved T-cell repertoires involved in allorecognition of class II major histocompatibility complex. Proc Natl Acad Sci U S A 1995; 92: 8836-40.
29. Pannetier C, Even J, Kourilsky P,. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16: 176-81.
30. Bacsi S, De Palma R, Visentin GP, Gorski J, Aster RH,. Complexes of heparin and platelet factor 4 specifically stimulate T cells from patients with heparin-induced thrombocytopenia/thrombosis. Blood 1999; 94: 208-15. (Pubitemid 29300151)
31. Battaglia M, Andreani M, Manna M, Nesci S, Tonucci P, Persini B, et al. Coexistence of two functioning T-cell repertoires in healthy ex-thalassemics bearing a persistent mixed chimerism years after bone marrow transplantation. Blood 1999; 94: 3432-8. (Pubitemid 29536138)
32. + T cell immune responses. J Immunol Methods 2002; 261: 177-94. (Pubitemid 34175227)
33. + central and effector memory T cell subsets are largely distinct. Immunity 2003; 18: 193-204. (Pubitemid 36262995)
34. + T lymphocytes. Cancer Res 2004; 64: 8068-76. (Pubitemid 39446945)
35. + T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 2010; 125: 222-30.
36. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009; 30: 92-107.
37. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, et al. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 2010; 107: 14751-6.
38. Kurschus FC, Croxford AL, Heinen A, Wortge S, Ielo D, Waisman A,. Genetic proof for the transient nature of the Th17 phenotype. Eur J Immunol 2010; 40: 3336-46.
39. Bosco MC, Delfino S, Ferlito F, Battaglia F, Puppo M, Gregorio A, et al. Hypoxic synovial environment and expression of macrophage inflammatory protein 3α/CCL20 in juvenile idiopathic arthritis. Arthritis Rheum 2008; 58: 1833-8. (Pubitemid 351847538)
40. Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C,. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 2009; 39: 216-24.
41. Bending D, De La Pena H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B, et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009; 119: 565-72.
42. Doodes PD, Cao Y, Hamel KM, Wang Y, Farkas B, Iwakura Y, et al. Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 2008; 181: 329-37.
43. Genovese MC, Van den Bosch F, Roberson SA, Bojin S, Biagini IM, Ryan P, et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 2010; 62: 929-39.
44. Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 2009; 373: 633-40.